ZURICH (Reuters) - - Swiss drugmaker Roche Holding AG is buying Constitution Medical Investors (CMI), the U.S. developer of a testing system for blood diseases like anemia and leukemia, for an upfront $220 million, plus further contingent payments.
via Reuters: Health News Read More Here..
No comments:
Post a Comment